← All organizations
ProMetic Life Sciences
Also known as: ProMetic BioSciences Inc. | Prometic Biotherapeutics, Inc. | ProMetic BioTherapeutics, Inc | ProMetic BioTherapeutics, Inc. | ProMetic Life Sciences Inc. | ProMetic Pharma SMT Limited | Prometic Pharma SMT Ltd.
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2014First marketed drug
Jun 4, 2021First NDA
Jun 4, 2021Last known activity
Jun 4, 2021
Timeline
1990s
- Jan 1, 1992
ProMetic Life Sciences— Founded
2010s
- Aug 24, 2016
Telesta Therapeutics— Acquired
2020s
- Jun 4, 2021
plasminogen— NDA Organization
- Jun 4, 2021
plasminogen— NDA Secondary Org
Drugs by trial phase (9 distinct, 17 trials)
Phase 3 (3 own, 3 via acquisition)
Phase 1 (2 own, 1 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (17)
- NCT03642691Lead sponsorN/A—
- NCT03265171Lead sponsorN/A—
- NCT04068259Study directorPhase 1Sep 5, 2019
- NCT04068259Lead sponsorPhase 1Sep 5, 2019
- NCT03637049Lead sponsorPhase 1Jul 17, 2018
- NCT03184584Lead sponsorPhase 2/Phase 3Oct 1, 2017
- NCT03081598Study chairPhase 2May 29, 2017
- NCT03081598Lead sponsorPhase 2May 29, 2017
- NCT02955888CollaboratorPhase 2Jan 3, 2017
- NCT02955888Lead sponsorPhase 2Jan 3, 2017
- NCT02955888Study chairPhase 2Jan 3, 2017
- NCT02690714Lead sponsorPhase 2/Phase 3May 4, 2016
- NCT02269163Lead sponsorPhase 3Jan 26, 2016
- NCT02739217Lead sponsorPhase 2Dec 1, 2015
- NCT02538536Lead sponsorPhase 2Jul 1, 2015
Details
- Founded
- Laval, CA Jan 1, 1992
- First NDA
- Jun 4, 2021
- Last known activity
- Jun 4, 2021
Designations held
- Orphan drug